Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide

Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. Insulin delivery and diabetes medical device mak...
Streetwise Reports | August 6, 2019 |

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. Global biopharmaceutical company Mallinckrodt Plc (MNK:NYSE) announced today that it has ent...
Streetwise Reports | September 11, 2019 |

Buzz on the Bullboards: Interest rates are still high

Stocks on both sides of the border have wilted in this short trading week. Stocks have since suffered after the Bank of Canada said this week that it would hold its key interest rate at 5 per cent , a 22-year high. The rate pause is in line with economist expectation...
Jonathon Brown | September 7, 2023 |

Buzz on the Bullboards: A Bigger Picture for Smaller Caps

(Image via Blackberry Ltd.) The business of war weighs on the minds of investors and companies today. It is not just that, but the push to re-emerge from the COVID-19 pandemic to supply chain issues, business has been adapting. Take BlackBerry Limited ( TSX: BB...
Stockhouse Editorial | March 23, 2022 |

Buzz on the Bullboards: Bulls on the Buzzboards

Do you believe in parallel dimensions, alternate realities? Somewhere where there is no COVID, European tensions are just that – tense, market volatility is kept to a minimum. It is here, perhaps, in the inversed Buzz, where everything is “fine”...
Stockhouse Editorial | March 9, 2022 |

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...
Streetwise Reports | April 1, 2020 |

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. Diagnostic...
Streetwise Reports | March 26, 2020 |

Immunotherapy Firm Releases Data Showing Treatment Potential Against Sepsis

Recently presented results from Enlivex Therapeutics' Phase 1b study in sepsis and their implications are reviewed in an H.C. Wainwright & Co. report. In a June 1 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Enlivex Therapeutics Ltd.'s ...
Streetwise Reports | June 4, 2020 |

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery

Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. This morning, medical device company TransEnterix Inc. (TRXC:NYSE.American) , whic...
Streetwise Reports | January 15, 2020 |

Important Economic News Calendar: November 4 – November 8, 2019

The markets will likely take some breather in the coming week following last week’s huge economic data announcements. But that does not mean there won’t be trading opportunities coming from the data releases. Last week we asked if quarterly corp...
Paul Rejczak | November 4, 2019 |
1 2 3 4 5 6 7 8 9 10 ...